Science to practice: Can macrophage infiltration serve as a surrogate marker for stem cell viability?

Radiology

Volumn 264, Issue 3, 2012, Pages 619-620

  Bulte, Jeff W M ^a   Morgan, Russell H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; FERUMOXYTOL; MITOMYCIN C; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADIPOSE DERIVED STEM CELL; APOPTOSIS; ARTICULAR CARTILAGE; BONE DEFECT; CARTILAGE CELL; CELL INFILTRATION; CELL LABELING; CELL SURVIVAL; CELL VIABILITY; HUMAN; HYDROGEL; KNEE INJURY; MACROPHAGE; MECHANICAL STRESS; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCHONDRAL DEFECT; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SHORT SURVEY; SIGNAL NOISE RATIO;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL SURVIVAL; CONTRAST MEDIA; DEXTRANS; HUMANS; KNEE INJURIES; MACROPHAGE ACTIVATION; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NANOPARTICLES; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84865410309     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12121378     Document Type: Short Survey

References (7)

1. Bulte JW. In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol 2009;193(2): 314-325.
2. Khurana A, Nejadnik H, Gawande R, et al. Intravenous ferumoxytol allows noninvasive MR imaging monitoring of macrophage migration into stem cell transplants. Radiology 2012;264(3):803-811.
3. Zscharnack M, Hepp P, Richter R, et al. Repair of chronic osteochondral defects using predifferentiated mesenchymal stem cells in an ovine model. Am J Sports Med 2010;38(9):1857-1869.
4. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5(3):309-313.
5. Lyons FG, Al-Munajjed AA, Kieran SM, et al. The healing of bony defects by cell-free collagen- based scaffolds compared to stem cellseeded tissue engineered constructs. Biomaterials 2010;31(35):9232-9243.
6. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67(10):1187-1194.
7. Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009;325(5940):612-616.